Evidence for angiotensin IV receptors in human collecting duct cells

被引:41
作者
Czekalski, S [1 ]
Chansel, D [1 ]
Vandermeersch, S [1 ]
Ronco, P [1 ]
Ardaillou, R [1 ]
机构
[1] HOP TENON,INSERM 64,F-75020 PARIS,FRANCE
关键词
D O I
10.1038/ki.1996.419
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Because angiotensin II (Ang II) has been found at high concentrations in the proximal tubule fluid and because tubular brush border membranes exhibit a marked capacity for degrading Ang II, we thought it of interest to examine the binding sites for Ang II (3-8) (referred to as Ang IV), a metabolite of Ang II, downstream in the nephron. We studied the binding of [I-125]-Ang IV and also of [I-125]-Sar(1), Ala(8), Ang II to SV-40 transformed human collecting duct cell (HCD) membranes. No specific binding site for [I-125]-Sar(1), Ala(8), Ang II and no Ang II-dependent cytosolic calcium response could be observed. Moreover, no signal for the human type I Ang II receptor (hAT(1)) mRNA was present in HCD cells. In contrast, [I-125]-Ang IV bound specifically to HCD cell membranes. Mean K-d and B-max values derived from saturation binding studies were 5.6 +/- 2.0 nM and 1007.6 +/- 140.2 fmol/mg protein, respectively. The rank order of affinity for competitive Ang II-related peptides was: Ang IV > Ang III > Ang II > Ang II (4-8) > Ang II (1-7). [I-125]-Ang IV binding was not modified by nonpeptide AT(1) (losartan) or AT(2) (PD123177) antagonists. GTP gamma S and dithiotreitol did not affect [I-125]-Ang IV binding. Ang IV stimulated cAMP production by intact HCD cells in the presence of forskolin but did not modify cGMP production or cytosolic calcium concentration, Taken together, these results indicate that HCD cells represent a target site for Ang IV but do not possess Ang II receptors.
引用
收藏
页码:1125 / 1131
页数:7
相关论文
共 33 条
  • [1] ABHOLD RH, 1988, J PHARMACOL EXP THER, V245, P171
  • [2] PROXIMAL TUBULAR SECRETION OF ANGIOTENSIN-II IN RATS
    BRAAM, B
    MITCHELL, KD
    FOX, J
    NAVAR, LG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05): : F891 - F898
  • [3] BREYER M, 1991, J CLIN INVEST, V88, P502
  • [4] DIFFERENTIAL REGULATION OF ANGIOTENSIN-II AND LOSARTAN BINDING-SITES IN GLOMERULI AND MESANGIAL CELLS
    CHANSEL, D
    BIZET, T
    VANDERMEERSCH, S
    PHAM, P
    LEVY, B
    ARDAILLOU, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (03): : F384 - F393
  • [5] Regulation of angiotensin II receptor subtypes by dexamethasone in rat mesangial cells
    Chansel, D
    LlorensCortes, C
    Vandermeersch, S
    Pham, P
    Ardaillou, R
    [J]. HYPERTENSION, 1996, 27 (04) : 867 - 874
  • [6] RABBIT RENAL EPITHELIAL ANGIOTENSIN-II RECEPTORS
    DULIN, NO
    ERNSBERGER, P
    SUCIU, DJ
    DOUGLAS, JG
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1994, 267 (05): : F776 - F782
  • [7] ERDOS EG, 1990, KIDNEY INT, V38, pS24
  • [8] MOLECULAR-CLONING AND SEQUENCING OF THE GENE ENCODING HUMAN ANGIOTENSIN-II TYPE-1 RECEPTOR
    FURUTA, H
    GUO, DF
    INAGAMI, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (01) : 8 - 13
  • [9] IDENTIFICATION AND CHARACTERIZATION OF A NOVEL ANGIOTENSIN BINDING-SITE IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS THAT IS SPECIFIC FOR THE HEXAPEPTIDE (3-8) FRAGMENT OF ANGIOTENSIN-II, ANGIOTENSIN-IV
    HALL, KL
    HANESWORTH, JM
    BALL, AE
    FELGENHAUER, GP
    HOSICK, HL
    HARDING, JW
    [J]. REGULATORY PEPTIDES, 1993, 44 (02) : 225 - 232
  • [10] HANESWORTH JM, 1993, J PHARMACOL EXP THER, V266, P1036